Posted inMarket
Why a Swiss Pharmaceutical Setback is Dragging Down the Dow Jones
Discover how a recent late-stage clinical trial failure by a Swiss pharmaceutical company is disproportionately impacting Dow Jones futures compared to the S&P 500.
